20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
One of the most persistent sources of confusion in business conversations about AI is the habit of treating ‘AI’ as a single, monolithic technology. It…
Read more
This is the second article in a three-part series on designing and implementing a fit-for-purpose Target Operating Model. In Part I, we explored how to…
Read more
Ask ten business leaders how their AI transformation is progressing, and nine will tell you it’s going well. Ask their finance directors how much measurable…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
